# Task B03: GLP testing of Doxycycline Efficacy in a Cynomolgus macaque inhalational model of Yersinia pestis infection.

> **NIH NIH N01** · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · 2021 · $76,459

## Abstract

This contract provides for the development and standardization of non-human primate models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.

## Key facts

- **NIH application ID:** 10489654
- **Project number:** 272201700012I-P00004-27200006-1
- **Recipient organization:** BATTELLE CENTERS/PUB HLTH RES & EVALUATN
- **Principal Investigator:** JAMES GRIDLEY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $76,459
- **Award type:** —
- **Project period:** 2018-09-15 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10489654

## Citation

> US National Institutes of Health, RePORTER application 10489654, Task B03: GLP testing of Doxycycline Efficacy in a Cynomolgus macaque inhalational model of Yersinia pestis infection. (272201700012I-P00004-27200006-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10489654. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*